It can be argued that all the stigmata of rosacea are manifestations of an inflammatory process: neutrophilic dermatosis. For this reason, treatments that block neutrophil involvement in the ...

Laser treatments are the most common option for rosacea, and they’re relatively safe and well-tolerated. They typically involve multiple sessions to effectively manage visible veins and ...

Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

When shopping for rosacea treatments, dermatologists recommend considering the following key factors: Want more from NBC Select? Sign up for our newsletter, The Selection, and shop smarter.

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new treatment for inflammatory skin conditions such as rosacea. Skin cells called ...

ACU-D1 is under development for the treatment of severe acne rosacea and HPV associated vulvar and perianal lesions in people with HIV. The drug candidate is a cinnamate compound. The drug candidate ...

Researchers say a compound called SYM2081 inhibits inflammation-driving mast cells in mice and human skin samples paving the ...

Living with skin that’s prone to rosacea isn’t easy. Trying to pin down a trigger for your redness can be exhausting: It could be stress, extreme temperatures, spicy foods, fragrance ...

As menopause is a natural part of aging and there is no cure for rosacea, treatments aim to reduce the symptoms. Managing the emotional and physical effects of rosacea and menopause can be ...

Rosacea is a common skin condition that causes ... listening to their concerns and creating a treatment plan with each patient's priorities and real life in mind. She is a member of the voluntary ...

which is also only approved for the treatment of inflammatory lesions in rosacea, but has become the standard treatment in the US. Another consideration is that the first generic versions of ...